Respiratory Meds etc Flashcards
meds for treatment of Bronchospastic Disorders
-Bronchodilators
-Beta-2 receptor agonists (short-acting and long-acting),
anticholinergics (also known as antimuscarinics),
-methylxanthines in a variety of aerosol, oral and I.V. formulations.
Long Acting Beta-2 Receptor Agonists (arformoterol, formoterol, indacaterol, olodaterol, salmeterol, vilanterol)
Beta-2 Receptor Agonist Bronchodilators-SHORT-ACTING–ALBUTEROL
Although supposed to be a selective Beta-2 agonist, it activates Beta-1 receptors to some extent
- Useful in allergic asthma and in exercise-induced asthma
-CNS stimulation
Beta-2 Receptor Agonist Bronchodilators- -SHORT-ACTING-METAPROTERENOL
Administered orally as a syrup
Less effective for prophylaxis in exercise-induced asthma
o Less potent than albuterol
o Contraindicated in patients having an arrhythmia at the planned time of drug administration
Beta-2 Receptor Agonist Bronchodilators-SHORT-ACTING-TERBUTALINE
Beta-2 agonist, BUT has a fairly strong affinity and intrinsic activity on Beta-1 receptors.
- Fewer C.V. adverse effects when compared to epinephrine
-Not selective for the Beta-2 receptors
-Very likely to cause cardiovascular adverse effects; tachycardia, palpitations, hypertension, angina, tremors, and arrhythmias
-May cause paradoxical bronchospasm when administered by inhalation
-Expensive
-Contraindicated in patients having an arrhythmia at the planned time of the drug’s administration
Long Acting Beta-2 Receptor Agonists (arformoterol, formoterol, indacaterol, olodaterol, salmeterol, vilanterol)
-SELECTIVE
- Only administered as an inhalant.
- Longer duration of action 12-24hours
-Useful for prophylaxis of allergic and exercise-induced asthma
- Cannot be used to treat an acute attack of asthma
-black box” warning regarding a risk of asthma-related death (only in single entity long acting beta agonist products not the combination products)
- Contraindicated in patients with severe hypersensitivity to milk proteins
Anticholinergic (antimuscarinic) Bronchodilator Drugs; aclidinium (Tudorza)
glycopyrrolate (Seebri) (Lonhala)
ipratropium (Atrovent)
tiotropium (Spiriva)
umeclidinium (Incruse)
revefenacin (Yupelri)
antagonists to acetylcholine on muscarinic receptors located on the smooth muscle cells that make up the wall of the bronchi and bronchioles
- Only administered as an inhalant.
-Can be used to treat bronchospasm in asthma, chronic bronchitis and emphysema; as monotherapy, they are less effective in asthmatics than in chronic bronchitis and emphysema. In asthmatics, they are commonly prescribed together with a Beta-2 bronchodilator
-May cause dry mouth, blurred vision and drying of respiratory secretion
-Contraindicated in glaucoma
-May cause acute urinary retention in older adult men with (BPH);
Xanthine Bronchodilators; theophylline (Elixophylline) (Slo-phylline) (Theodur) (many others)
aminophylline (Aminophylline)
Stimulates the respiratory drive center in the brainstem;
Stimulates respiratory cilia; improves the mucus clearance(pts with chronic bronchitis)
Increases the contractile strength of the diaphragm; increases the force of the respiratory effort(helps pts with muscle weakness)
- Decreases pulmonary artery resistance; improves pulmonary blood flow and improves perfusion and oxygenation
-narrow margin of safety and low therapeutic index
Declined in importance in the treatment of asthma.
Xanthine Bronchodilators; Serum levels are increased in
- neonates and older adults
- liver disease
- congestive heart failure
- concomitant use of Beta-blockers
- concomitant use of erythromycin
- concomitant use of cimetidine (Tagamet)
- concomitant use of oral contraceptives
Xanthine Bronchodilators; Serum levels are decreased in
hildren age 1-16 years
9. cigarette smokers
10. concomitant use of phenobarbital
11. concomitant use of phenytoin (Dilantin)
12. concomitant use of rifampin
13. concomitant use of ketoconazole
Drugs Used For Treatment of Respiratory Inflammation
Leukotriene modifiers, corticosteroids and cromones
Leukotriene Modifiers;
zafirlukast (Accolate)
montelukast (Singulair)
zileuton (Zyflo/CR)
Zafirlukast and montelukast are leukotriene antagonists, meaning they block various leukotriene receptors. Zileuton is a 5-lipoxygenase inhibitor, which inhibits the formation of leukotrienes.
-prophylactically in asthma
-good for exercise-induced asthma
requires the presence of other anti-asthma medications to produce a desirable therapeutic response.
-known to cause neuropsychiatric events
-Not useful in acute bronchospasm
what are Leukotrienes
Leukotrienes are a type of inflammatory biomediator in the lung and have been shown to play a significant role in asthma and allergy. Use of these modifier drugs may prevent leukotriene-induced inflammation.
Zafirlukast is
a hepatic enzyme inhibitor; it is capable of increasing the serum concentrations of other drugs (pharmacokinetic potentiative drug-drug interaction)
- Zafirlukast must be taken on an empty stomach
Corticosteroid Drugs examples
ntravenous
o hydrocortisone (Solu-Cortef)
o methylprednisolone (Solu-Medrol)
- Oral
o hydrocortisone (Hydrocortone)
o prednisone (Deltasone)
o dexamethasone (Decadron)
o betamethasone (Celestone)
- Inhalational / Nasal
beclomethasone (QVAR) / (Beconase)
o budesonide (Pulmicort) / (Rhinocort)
o fluticasone (Flovent, Armonair, Arnuity, Flovent))/ (Flonase)e
(Nasacort)**available OTC